Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Jul;8(7):E578-80.
doi: 10.21037/jtd.2016.05.19.

To stop or continue aspirin before aortocoronary bypass operations-do we have enough evidence to adequately guide us?

Elisabeth Mahla  1 , Udaya S Tantry  2 , Paul A Gurbel  2
Affiliations
Comment

To stop or continue aspirin before aortocoronary bypass operations-do we have enough evidence to adequately guide us?

Elisabeth Mahla et al. J Thorac Dis. 2016 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Dr. Gurbel receivived honoraria and payment for lectures, including service on speakers’ bureaus from Daiichi Sankyo/Lilly, AstraZeneca and Merck. Dr. Gurbel is holding stock or stock options in Merck, Medtronic, and Pfizer; and holding patents in the area of personalized antiplatelet therapy and interventional cardiology. Dr. Mahla received payment for lectures from Astra Zeneca and Boehringer Ingelheim.

Comment on

  • Stopping vs. Continuing Aspirin before Coronary Artery Surgery.
    Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, Wallace S; ATACAS Investigators of the ANZCA Clinical Trials Network. Myles PS, et al. N Engl J Med. 2016 Feb 25;374(8):728-37. doi: 10.1056/NEJMoa1507688. N Engl J Med. 2016. PMID: 26933848 Clinical Trial.

References

    1. US Preventive Services Task Force . Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;150:396-404. 10.7326/0003-4819-150-6-200903170-00008 - DOI - PubMed
    1. Mangano DT, Multicenter Study of Perioperative Ischemia Research Group . Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002;347:1309-17. 10.1056/NEJMoa020798 - DOI - PubMed
    1. Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 2006;27:2667-74. 10.1093/eurheartj/ehl334 - DOI - PubMed
    1. Patrono C, Baigent C, Hirsh J, et al. Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:199S-233S. - PubMed
    1. Tantry US, Mahla E, Gurbel PA. Aspirin resistance. Prog Cardiovasc Dis 2009;52:141-52. 10.1016/j.pcad.2009.05.001 - DOI - PubMed

LinkOut - more resources